ADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.83 million

• ADAR1 Capital Management raised its indirect stake in Tenax Therapeutics to 4,853,818 common shares.
• Daniel Schneeberger, manager, reported the position as indirectly held through private investment funds managed by ADAR1.
• Purchases were reported at weighted-average prices of USD 1.78, USD 1.77, USD 1.75 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000017), on August 24, 2026, and is solely responsible for the information contained therein.